Fundraising Fox

scPharmaceuticals

Lexington, US · Founded 2014 · Delaware corporation · 1 known investors

Biotech

Founders & leadership

PM
Pieter MuntendamNamed on SEC filing

Board

MK
Mette Kirstine AggerBoard director
KPKush Parmar
Kush ParmarinBoard of Directors2014–2018Managing Partner at 5AM Ventures
DC
Dorothy ColemanBoard director
LS
Leonard SchaefferBoard director

Investors · 1

5AM VenturesBoston · $100K – $4M

Reported raises · per SEC filings

Form D private placements

$71.8M disclosed across 5 rounds · 2014–2016

▶$47MraisedJan 2017 · 11 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Dorothy ColemanDirector
  • Abraham CeesayExecutive Officer
  • Troy IgnelziExecutive Officer
  • Kush ParmarDirector
  • Leonard SchaefferDirector
  • Mette AggerDirector
  • Pieter MuntendamExecutive Officer, Director
  • Jack KhattarDirector
  • Abhay GandhiDirector
  • Jonathan SilversteinDirector
Offering amount
$47M
Amount sold
$47M
First sale
Dec 2016
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8.2MraisedSep 2016 · 15 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Leonard SchaefferDirector
  • Abraham CeesayExecutive Officer
  • Pieter MuntendamExecutive Officer, Director
  • Kush ParmarDirector
  • Jack KhattarDirector
  • Troy IgnelziExecutive Officer
  • Mette AggerDirector
  • Dorothy ColemanDirector
Offering amount
$8.2M
Amount sold
$8.2M
First sale
Aug 2016
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4MraisedSep 2016 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Pieter MuntendamExecutive Officer, Director
  • Mette AggerDirector
  • Jack KhattarDirector
  • Dorothy ColemanDirector
  • Kush ParmarDirector
  • Leonard SchaefferDirector
  • Abraham CeesayExecutive Officer
  • Troy IgnelziExecutive Officer
Offering amount
$10M
Amount sold
$4M
Proceeds to insiders
$468.6K
First sale
Aug 2016
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.6MraisedFeb 2016 · 12 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Pieter MuntendamExecutive Officer, Director
  • Mette Kirstine AggerDirector
  • Dorothy ColemanDirector
  • Leonard SchaefferDirector
  • Kush ParmarDirector
Offering amount
$7.5M
Amount sold
$3.6M
Proceeds to insiders
$171.8K
First sale
Jan 2016
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$9.1MraisedApr 2014 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Pieter MuntendamExecutive Officer, Director
  • Mette Kirstine AggerDirector
  • Kush ParmarDirector
Offering amount
$17.1M
Amount sold
$9.1M
First sale
Mar 2014
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

CT drugmaker raises $50M after FDA approval of new treatmenthartfordbusiness.com · Jul 2026MannKind stock falls after announcing acquisition of scPharmaceuticals By Investing.cominvesting.com · Aug 2025scPharmaceuticals Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update - BioSpacebiospace.com · Aug 2025scPharmaceuticals Secures Funding, Advances FUROSCIX Commercialization - TipRanks.comtipranks.com · Aug 2024scPharmaceuticals Announces Closing of $45.6 Million in Series B Financingprnewswire.com · Jan 2017Buy scPharmaceuticals Stock – SCPH Stock Quote Today & Investment Insights - Public.compublic.com

Frequently asked questions

Who are scPharmaceuticals's investors?
scPharmaceuticals's investors include 5AM Ventures.
How much funding has scPharmaceuticals raised?
scPharmaceuticals has disclosed $71.8M raised across 5 rounds.
Where is scPharmaceuticals headquartered?
scPharmaceuticals is headquartered in Lexington, US.